Hasandalan, Johndejay G.

HRN: 16-32-65  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2024
CEFTRIAXONE 1G (VIAL)
11/02/2024
11/08/2024
IV
2g
Q12h
Orbital Apex Syndrome Prob Infectious In Origin
Waiting Final Action 
11/02/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/02/2024
11/08/2024
IV
500mg
Q6h
Orbital Apex Syndrome Prob Infectious In Origin
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: